| | | | | |
 |
| | | Andreae LC, Ben Fredj N et al. | J Neurosci (2012) | 22302825 |
| Independent Vesicle Pools Underlie Different Modes of Release during Neuronal Development. |
| |
| | | Stanton-Humphreys MN et al. | Chem Commun (Camb) (2012) | 21980596 |
| Wavelength-orthogonal photolysis of neurotransmitters in vitro. |
| |
| | | Tossell K, Andreae LC et al. | Dev Biol (2011) | 21315708 |
| Lrrn1 is required for formation of the midbrain-hindbrain boundary and organiser through regulation of affinity differences between midbrain and hindbrain cells in chick. |
| |
| | | McGuinness L, Taylor C et al. | Neuron (2010) | 21172613 |
| Presynaptic NMDARs in the hippocampus facilitate transmitter release at theta frequency. |
| |
| | | Burlakov VM, Taylor R et al. | Biophys J (2010) | 20816048 |
| Analysis of microscopic parameters of single-particle trajectories in neurons. |
| |
| | | Andreae LC, Lumsden A et al. | Neural Dev (2009) | 19602272 |
| Chick Lrrn2, a novel downstream effector of Hoxb1 and Shh, functions in the selective targeting of rhombomere 4 motor neurons. |
| |
| | | Morice E, Andreae LC et al. | Learn Mem (2008) | 18626093 |
| Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. |
| |
| | | Andreae LC, Peukert D et al. | Neural Develop (2007) | 17973992 |
| Analysis of Lrrn1 expression and its relationship to neuromeric boundaries during chick neural development. |
| |
| | | Strøbaek D, Hougaard C et al. | Mol Pharmacol (2006) | 16926279 |
| Inhibitory gating modulation of small conductance Ca2+-activated K+ channels by the synthetic compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reduces afterhyperpolarizing current in hippocampal CA1 neurons. |
| |
| | | Chalmers RM, Andreae L et al. | J Neurol Neurosurg Psychiatry (1999) | 10577029 |
| Familial hydrocephalus. |
| |
| | | Andreae LC, Herbert J | Neuroscience (1993) | 8487952 |
| Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and corticotropin-releasing factor. |
| |
|